Dultavax

Dultavax is a vaccine designed to protect against diphtheria, tetanus, and poliovirus. It combines inactivated components to help prevent these serious infections. Ideal for routine immunization, it supports public health efforts against these diseases.

Dultavax is primarily used for the prevention of diphtheria, tetanus, and poliovirus infections. It is administered to individuals who require protection against these diseases, often as part of a routine vaccination schedule. The vaccine helps the body develop immunity to these infections, which can be severe or life-threatening.

Common effects of Dultavax may include mild redness, swelling, or soreness at the injection site. Some individuals might experience mild fever, fatigue, or muscle aches following vaccination. These effects are generally temporary and resolve on their own.

Dultavax should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or allergies before receiving the vaccine.

Dultavax may interact with certain medications or other vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Additionally, the vaccine should not be administered simultaneously with other live vaccines without medical supervision.